Developing vaccines against flavivirus diseases: past success, present hopes and future challenges.


Stephenson, JR; (2006) Developing vaccines against flavivirus diseases: past success, present hopes and future challenges. Novartis Foundation symposium, 277. 193-201; discussion 201-5, 251-3. ISSN 1528-2511

Full text not available from this repository.

Abstract

Vaccination still remains the most cost-effective way of protecting large populations against infectious disease. Safe and effective vaccines are available against most pathogenic flaviviruses and in recent years substantial progress has been made in developing vaccines against dengue. Dengue vaccines based on conventional and recombinant DNA technologies are being assessed and initial results are encouraging. Many other experimental vaccines have been developed, but despite the intensity of effort, concerns about the safety of new vaccines appear to be hindering their development. With the global threat from dengue increasing, might it now be the time to consider a less risk-averse approach?

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Immunology and Infection
Research Centre: Vaccine Centre
PubMed ID: 17319163
URI: http://researchonline.lshtm.ac.uk/id/eprint/10355

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
290Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item